These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 35000713)
1. A Case of High-Output Heart Failure. Murray E; Taylor J; Hountras P Chest; 2022 Jan; 161(1):e23-e28. PubMed ID: 35000713 [TBL] [Abstract][Full Text] [Related]
7. An uncommon cause of heart failure. Church AC; Quinnell T QJM; 2007 Feb; 100(2):139. PubMed ID: 17164323 [No Abstract] [Full Text] [Related]
8. [A case of transcatheter coil embolization for pulmonary arteriovenous malformation complicated with hepatic arteriovenous malformation]. Takahashi M; Yamada G; Sawazumi T; Nakamura N; Fujii M; Inomata S; Chiba H; Takahashi H Nihon Kokyuki Gakkai Zasshi; 2009 Dec; 47(12):1103-7. PubMed ID: 20058687 [TBL] [Abstract][Full Text] [Related]
9. Worsening of nose bleeding heralds high cardiac output state in hereditary hemorrhagic telangiectasia. Khalid SK; Pershbacher J; Makan M; Barzilai B; Goodenberger D Am J Med; 2009 Aug; 122(8):779.e1-9. PubMed ID: 19635281 [TBL] [Abstract][Full Text] [Related]
10. Hepatic artery embolization for treatment of patients with hereditary hemorrhagic telangiectasia and symptomatic hepatic vascular malformations. Chavan A; Caselitz M; Gratz KF; Lotz J; Kirchhoff T; Piso P; Wagner S; Manns M; Galanski M Eur Radiol; 2004 Nov; 14(11):2079-85. PubMed ID: 15316741 [TBL] [Abstract][Full Text] [Related]
15. Peripheral arterial coil embolization for hepatic arteriovenous malformation in Osler-Weber-Rendu disease; useful for controlling high output heart failure, but harmful to the liver. Hisamatsu K; Ueeda M; Ando M; Koike K; Matsuo N; Matsu-ura K; Ueda H; Hirohata M; Imai M Intern Med; 1999 Dec; 38(12):962-8. PubMed ID: 10628935 [TBL] [Abstract][Full Text] [Related]
16. Embolization of hepatic arteriovenous malformations using radiolabeled and nonradiolabeled polyvinyl alcohol sponge in a patient with hereditary hemorrhagic telangiectasia: case report. Whiting JH; Morton KA; Datz FL; Patch GG; Miller FJ J Nucl Med; 1992 Feb; 33(2):260-2. PubMed ID: 1732452 [TBL] [Abstract][Full Text] [Related]
17. Bevacizumab reverses need for liver transplantation in hereditary hemorrhagic telangiectasia. Mitchell A; Adams LA; MacQuillan G; Tibballs J; vanden Driesen R; Delriviere L Liver Transpl; 2008 Feb; 14(2):210-3. PubMed ID: 18236396 [TBL] [Abstract][Full Text] [Related]
18. Hereditary hemorrhagic telangiectasia: effective protocol for embolization of hepatic vascular malformations--experience in five patients. Chavan A; Galanski M; Wagner S; Caselitz M; Schlitt HJ; Gratz KF; Manns M Radiology; 1998 Dec; 209(3):735-9. PubMed ID: 9844667 [TBL] [Abstract][Full Text] [Related]
19. Long-term outcome of patients with hereditary hemorrhagic telangiectasia and severe hepatic involvement after orthotopic liver transplantation: a single-center study. Dupuis-Girod S; Chesnais AL; Ginon I; Dumortier J; Saurin JC; Finet G; Decullier E; Marion D; Plauchu H; Boillot O Liver Transpl; 2010 Mar; 16(3):340-7. PubMed ID: 20209594 [TBL] [Abstract][Full Text] [Related]
20. [Rendu-Osler disease with hepatic involvement: first transplant in Spain]. Núñez Viejo MA; Fernández Montes A; Hernández Hernández JL; Pons Romero F; Fábrega García E; Zarrabeitia R Med Clin (Barc); 2010 Oct; 135(12):552-5. PubMed ID: 20627321 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]